Pfizer and Biohaven get EC approval for Vydura to treat and prevent migraine
Vydura is indicated for acute treatment of migraine regardless of aura, and prophylaxis (prevention) of episodic migraine in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Apr 22
Vydura is indicated for acute treatment of migraine regardless of aura, and prophylaxis (prevention) of episodic migraine in…
26 Apr 22
Veklury is indicated for patients who are admitted to the hospital or have a mild-to-moderate disease and are…
25 Apr 22
The company’s decision to withdraw follows consultation with the CHMP, which suggested that the data provided so far…
19 Apr 22
The British drugmaker’s regulatory submission was based on the Phase 3 ASCEND clinical trial programme, where all the…
19 Apr 22
Nuvaxovid is the first recombinant protein-based Covid-19 vaccine approved in Japan and is based on efficacy and safety…
18 Apr 22
Spikevax was previously authorised by the MHRA for use in adults aged 18 years and above, and for…
13 Apr 22
ExoFlo is an acellular human bone marrow mesenchymal stem cell (MSC) obtained EV product developed leveraging Direct Biologics’…
11 Apr 22
The vaccine will be produced by SII under the brand name Covovax and is authorised for active immunisation…
08 Apr 22
The EC approval is based on pivotal findings from the double-blind, randomised, placebo-controlled Phase III VOYAGE clinical trial…
07 Apr 22
The US FDA approval was based on positive results from EPIK-P1, a retrospective chart review study of Vijoice…